AVRA Medical Robotics

Orlando
Florida
United States

Website: http://allaboutroboticsurgery.com/

Email: info@avramedical.com

Show jobs for this employer

About AVRA Medical Robotics

AVRA Medical Robotics is planning to enter the medical robotics field through the development of an intelligent medical robotic system for skin resurfacing procedures, in partnership with the University of Central Florida (“UCF”). AVRA was organized by a senior leadership team with broad and deep experience in medical research, innovation and development in the medical robotics field. AVRA is concentrating on the growing demand for practical medical robotic devices by developing a platform-independent precision guidance system, applicable to a variety of minimally invasive and non-invasive procedures, with an initial focus on skin resurfacing. The skill and experience of its leadership team is enhanced by the active participation in development of UCF, which is recognized particularly for its work in the area of medical robotics research and design. Moreover, AVRA’s leadership team is also experienced in marketing, chain management, and the implementation of all other aspects of business operations.
YEAR FOUNDED:
February 4, 2015
LEADERSHIP:
CEO: Barry F. Cohen
VP, Global Business Development: Alexandre Clug

8 articles about AVRA Medical Robotics

  • AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR), a medical robotics software and artificial intelligence company announced that it is continuing to progress to consummation of its acquisition by merger of CardioVentures, Inc. (“CardioVentures”), as previously reported in its Current Report on Form 8-K filed with the SEC on November 7, 2022.

  • AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTCMKTS: AVMR) today issued the following update letter by its CEO, Barry Cohen to shareholders and the investment community:

  • AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update:

  • AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update: Despite the difficulties presented by the COVID-19 Pandemic, the Company continues to make progress on developing its proprietary Medical Robotic System. As AVRA CEO Barry Cohen explains, “The latest test results of AVRA’s Imaging and Detection System software designed to Detect, Identify, Diagnose, and Deliver an autonomous robotic surgical pr

  • AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), today announces that its Chairman & CEO, Barry Cohen, has increased his stake in the company by approximately 5% by purchasing an additional 1,000,000 common shares of AVRA stock.

  • AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company building a fully autonomous medical robotic system combining artificial intelligence, machine learning and proprietary software, today announces that it has paid off almost all of its external corporate debt, including accrued interest.

  • AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software; is attending the 38th J.P. Morgan Healthcare Conference in San Francisco this week

  • Disruptive Autonomous Surgical System Implements oVio’s Revolutionary Imaging Technology